Early View

Letter to the Editor

Mark J. Ratain,

Corresponding Author

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA

Correspondence: Mark J. Ratain (mjr1@uchicago.edu)

Search for more papers by this authorCody J. Peer,

Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA

Search for more papers by this authorWilliam D. Figg,

Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA

Search for more papers by this authorDaniel A. Goldstein,

Tel Aviv University, Tel Aviv, Israel

Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel

Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA

Search for more papers by this author PDF ShareShare Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.